Insensitivity to scope in contingent valuation studies: new direction for an old problem

Editorial

Jennifer A Whitty. Appl Health Econ Health Policy. 2012.

. 2012 Nov 1;10(6):361-3.

doi: 10.1007/BF03261871.

No abstract available

Comment on

What explains willingness to pay for smoking-cessation treatments - addiction level, quit-rate effectiveness or the opening bid?
Olsen JA, Røgeberg OJ, Stavem K. Olsen JA, et al. Appl Health Econ Health Policy. 2012 Nov 1;10(6):407-15. doi: 10.1007/BF03261875. Appl Health Econ Health Policy. 2012. PMID: 22938035
Insensitivity to scope in contingent valuation studies: reason for dismissal of valuations?
Søgaard R, Lindholt J, Gyrd-Hansen D. Søgaard R, et al. Appl Health Econ Health Policy. 2012 Nov 1;10(6):397-405. doi: 10.1007/BF03261874. Appl Health Econ Health Policy. 2012. PMID: 22963163